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Introduction: Bone surgery as a current bone treatment method is not always successful to fulfil bone repair in bone degenerative diseases or 
extensive injuries. Due to the limited capacity of bone remodeling, the demand for alternative approaches remains to be met. Thus, efforts in ex 
vivo generation of bone forming cells, osteoblasts, and their further application in cell therapy as a promising approach are of vital prominence 
from a scientific perspective. Though several studies have focused on microRNA roles in osteoblast differentiation in various cell recourses, yet 
none has reported miR-210 enhancing role in human mesynchymal stem cells (MSCs) so far. Materials and Methods: Hence, we wished to 
examine the nature of the relationship between osteoblast differentiation and miR-210 in unique human mesynchymal stem cells, unrestricted 
somatic stem cells (USSCs). Osteoblast markers at gene level namely, Runx2, col I in addition to osteocalcin were assessed using qRT-PCR, and 
Alizarin Red S staining was also carried out to observe histochemical changes 7 days following miR-210 transduction. Results: The conclusion 
that follows from our findings represents a marked increase in osteoblast differentiation markers. Interestingly, for the first time, human USSCs 
differentiation into osteoblasts was performed in our research. Conclusion: our study may provide helpful insights into surmounting bone 
related issues by combination of both gene and cell therapy.  
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Introduction 
The structure of bone has now been fully understood. Bone is 
resorbed and rebuilt by two major abundant bone residing cell types 
of osteoclasts and osteoblasts respectively, with distinct origins to 
maintain tissue hemostasis. From a scientific viewpoint, osteoblasts 
are of high importance due to their bone forming nature, hence 
these cells if generated ex vivo could be prime candidates to serve 
useful future bone treatment purposes(1). To attain the desired 
goal, molecular and genetic research has been constantly 
attempting to unravel the mysteries of osteoblast differentiation 
regulatory layers. The first and most well-known regulatory layer of 
osteoblast differentiation is the specific central transcription factors, 
Runt-related transcription factor 2 (Runx 2) and Osterix, which 
initiate and tightly regulate osteoblast differentiation. They target 
osteoblast-related genes such as osteocalcin, bone sialoprotein, 
osteopontin and collagen type Iα1. Other transcription factors such 
as Twist, Distal-Less Homeobox 5 (DLX5) inhibits Runx2 
transcriptional activity(2).More recently, it has been explained that 
the multi-layered regulation of osteoblasts is not solely restricted to 
transcription factors at gene level, but also is contributed and 
controlled by post transcriptional modulation epigenetically at 
protein level. Amongst the post transcriptional modulators, 
microRNAs are considered to mediate rapid fine-tuning of gene 
expression in specific tissues such as bone(3) MicroRNAs are 
classed as short noncoding single stranded RNAs and major 
epigenetic modulators of protein levels. These modulators exert 
their influence either by accelerating the target mRNAs degradation 
or blocking their translation. Biological significance of microRNAs 
has been understood in various multicellular organisms' processes 
ranging from metabolism, migration, proliferation, and apoptosis 
to differentiation. Among the investigated microRNAs, miR-133 
has been reported to regulate muscle differentiation (4). In addition 
to muscle differentiation, a growing number of microRNAs 
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regulating bone differentiation have been elucidated over the past 
recent years (5). Accordingly, miR-223 role has been demonstrated 
to control osteoclastogenesis in RAW 264.7 cells (6). Also, miR-26 
regulates osteogenic differentiation in human adipose tissue-
derived stem cells. Another research showed that miR-125b inhibits 
bone morphogenic protein-4 (BMP-4)-induced osteoblast 
differentiation in mouse mesenchymal ST2 stem cells (7). The 
inhibitory role of miR-214 in bone formation has been revealed in 
transgenic mice as well (8). MiR-206 connexin 43 ,which is a gap 
junction protein in osteoblasts, has been shown to be down 
regulated when miR-206 is overexpressed and conversely, its 
knockdown expression promoted osteoblast differentiation in 
C2C12 cells (2). miR-26a also inhibits osteoblast differentiation by 
targeting Smad1 in human adipose tissue derived stem cells (9). 
Yet, the role of miRNAs in the differentiation and recruitment 
of mature cells derived from mesenchymal stem cells (MSCs) or 
hematopoietic stem cells still remains to be established(1). 
Although miR-210 has already been claimed to be over-expressed 
during osteoblastic differentiation in mouse ST2 cell line, as far as 
we are concerned, no data to date have been reported on 
osteoblastic differentiation in human umbilical cord stem cell 
source by means of microRNAs. Thus, we aimed to assess the 
likely osteoblastic differentiation potential of miR-210 in a unique 
human derived cell source named unrestricted somatic stem cells 
(USSCs) cells by means of Lentivirus delivery. The newly emerged 
human umbilical cord blood stem cells known as USSCs have 
lately gained popularity due to their multitude favorable intrinsic 
properties in comparison with other stem cell resources (10). In 
principle, these cells are mainly renowned for their non-invasive 
isolation compared to bone marrow derived mesenchymal stem 
cells. Furthermore, no ethical issues has been addressed regarding 
their usage since they are discarded right after child birth and 
could be applied in research with maternal consent afterwards. In 
addition, they have been found to be highly potential of the three 
germ layer differentiation while remaining undifferentiated. 
Lastly, it is also worth mentioning that their long-term ex vivo 
expansion or maintenance would cause no transformation. Put 
simply, USSC characteristics have made them a promising cell 
source that can offer a new perspective on cell-based therapies and 
regenerative medicines (11-13). 
Materials and Methods 
Cell culture 
USSC was obtained from the Stem Cell Technology Research 
center (Tehran, Iran). Previously characterized USSCs were 
expanded in high DMEM medium (Gibco), supplemented with 
10 % FBS (Gibco). 
Transfection 
In order to achieve the entire Lentivirus production, initially, the 
vital plasmids, namely, packaging plasmid psPAX2, envelope 
plasmid pMD2.G as well as pLenti-III-GFP (scramble vector), and 
pLeX Turbo-GFP (miR-210 vector) were separately extracted from 
the 16 hour cultured bacteria in LB, according to the plasmid 
extraction kit procedure (Ferments). For the LipofectamineTM 2000 
transfection purposes, nearly 4×104 HEK293T cells were first 
cultured 24 hours earlier in a 10 mm plate nourished by DMEM and 
10 % FBS to reach 70 % of confluency in time for the transfection. 
Subsequently, the previously extracted plasmids and 
LipofectamineTM 2000 were each diluted in Opti-MEM a serum free 
medium and combined to form the oligomer-Lipofectamine 
complexes. The prepared complexes were added to the HEK293T 
plates and incubated at 37°C in a CO2 incubator thereafter in 
accordance with the manufacturer's instructions. 
Lentivirus production and harvesting  
16 hrs following the transfection day, HEK293T supernatant 
medium containing the newly formed complete Lentiviral particles 
were collected in falcons once per every 24 hrs for three days long 
and stored at -70°C for long term use. 
Transduction 
30% confluent adherent USSCs previously seeded in 16-well culture 
plates were transduced with filtered as well as concentrated 
Lentiviral particles. The efficiency of USSC transduction was 
enhanced with the addition of 8  µl polybren. 
Total RNA isolation 
Having harvested USSC samples at day 7th, the transduction effect of 
miR-210 was qualitatively and quantitatively assessed by GFP 
tracking via fluorescence microscopy and RNA extraction for further 
analysis by Real Time PCR respectively. The total RNA isolation was 
carried out with the aid of RNA X-plus lysis reagent in accordance 
with our provided RNA isolation protocol and followed by the RNA 
concentration quantification using AG bio photometer. 
qRT-PCR 
To meet the miR-210 detection, the total isolated RNA was reverse 
transcribed by RT enzyme provided by 1st cDNA synthesis kit 
(Thermo Scientific) and with an exclusively designed forward stem 
loop primer for miR-210 in addition to a forward primer of Snord 
47 used as an endogenous control and a universal reverse primer in 
TAKARA Thermo cycler. The primer sequences are respectively for 
miR-210: 5'- TGATTAGCCCCTGCCCAC -3' and for the internal 
control: 5' ATCACTGTAAAACCGTTCCA 3'. Using 1 µl of the 
consequent 1st cDNA as templates and SYBR Green/ROX qPCR 
Master Mix (TAKARA), the miR-210 expression level was 
measured utilizing the quantitative Real Time PCR (Applied 
biosystem), with the total cycle of 41.  
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Figure 1. HEK293Ttransfection fluorescence microscopy images after 
72 hrs 
 
Figure 2. A) Alizirin red staining of USSCs as control; B) Alizarin red 
staining of transduced cells after 7 d 
 
Figure 3. A) Fibroblastic morphology of USSCs under optical 




Figure 4. Real Time PCR shows 2.23, 1.6, 8.6-fold change in 
expression of Runx2, Osteocalcin and col I, respectively in miR-210 
treated USSCs at day 7th compared to the control 
For the purpose of qRT-PCR analysis in other words, quantify the 
difference between mRNA levels of osteogenic markers; the total 
RNA was isolated from all cell samples, using RNA-X plus 
reagent. After the RNA concentration measurements, cDNAs 
were synthetized by M MuL V Reverse Transcriptase and random 
hexamer primers in a sequential two-step process using TAKARA 
Thermo cycler. cDNA amplification in q-RT PCR begins with a 
cycle of the initial secondary structures denaturation for 30 
seconds at 95°C, followed by 40 cycles circulating 5 seconds of 
95°C denaturation and 30 seconds of annealing/extension. All 
reactions were performed in a minimum of duplicates and 
normalized to the internal control gene. Relative expression was 
quantified using ∆∆Ct method and changes in microRNA and 
mRNA expressions were normalized to the relevant internal 
control. The applied Biosystem was used for quantitative miRNA 
and mRNA transcript expressions. 
Alizarin red staining 
To assess the histochemical changes for osteoblastic 
differentiation, the Alizarin Red S staining (Sigma) was 
performed on USSC control cells in comparison with miR-210 
treated USSC cells following 7 days. Briefly, cells were first once 
washed with cold PBS and then fixed 20 minutes with 4 % 
Paraformaldehyde at 4°C. Immediately after fixation, the second 
wash with PBS and a 5-minute incubation at room temperature 
were carried out. Subsequently, the fixed cells were stained with 
prepared 2 % Alizarin red S with a pH of 7.2. Having added the 
stain slowly and drop-wise to the cells, cells were then incubated 
at room temperature. Not long after the incubation, stain was 
discarded and the final cell wash was done for optical 
microscopic examination and imaging (Figure 2).  
Results 
Transfection and packaging plasmids 
Transfection and Lentivirus production of pLEX TurboGFP vector 
of miR-210 as well as helping plasmids of psPAX, PMD2.G were 
packaged successfully by means of HEKT 293 and eventually miR-
210 Lentivirus production was readily detectible due to GFP marker 
presence in pLEX TurboGFP vector of miR-210. Therefore, GFP 
expression was detected via fluorescence microscopy 72 h after 
transfection in HEKT 293 cell line. Fluorescence microscopy 
imaging results are illustrated in Figure 1. 
Transduction 
USSC cells were twice transduced with newly produced miR-210 
Lentivirus. 72 hrs following transduction, GFP was detected. In 
this regard, expression of GFP in USSCs is presented in Figure 3. 
Mir-210 treatment 
223                                                                                                                                                                                                            Sahmani et al. 
 
Regeneration, Reconstruction & Restoration 2017;2(2):220-224 
Alizarin Red Staining 
Alizarin Red S staining (Sigma) was performed on USSC control 
cells in comparison with miR-210 treated USSCs following 7 
days. As depicted in Figure 2B, USSCs treated with miR-210 
lentiviral vector reveals presence of redish-brown color staining 
that could be interpreted as calcium nodules while Figure 2A 
represents Alizirin Red staining of USSCs as control cells. The 
absence of redish-brown color staining of mentioned cells that 
equates with no calcium nodules is noticed.  
MicroRNA and gene expression analysis 
Transduction results demonstrated a remarkable up regulation 
of miR-210 in USSCs after duration of 7 days. The expression of 
microRNA was compared with a control. Gene expression 
analyzed by Real Time PCR revealed that there was an increase 
in osteoblast markers namely, Runx2, col I as well as osteocalcin 
in comparison with the untreated USSCs. Gene expression 
analysis is illustrated in Figure 4. 
Discussion 
Significance of bone and the mounting concern for its 
associated defects today have resulted into attempts to 
differentiate distinct cell resources into bone generating cells, 
osteoblasts (14). In this regard, fine- tuning molecules known 
as microRNAs are gaining ground against the conventional 
methods of costly growth factor or osteogenic reagent 
applications in osteoblast differentiation. miR-210 cellular 
functions, that have been clarified in recent years, is a case in 
point. miR-210 is believed to be involved in cell proliferation 
inhibition by directly targeting E2F3 in a wide variety of cells 
(15). Studies dissecting mechanistic insight revealed that miR-
210 promotes stem cell survival via targeting caspase-8 
associated protein 2 (CASP8AP2), or its human homologue 
FLICE-associated protein homolog (FLASH), a protein that 
facilitates Fas-induced apoptosis (16). miR-210 can, in 
addition, act as an angiogenesis inducer in myocardial 
infarction as well as a potent mitochondrial repressor(17).  
Based on recent data, miR-210 has been claimed to be 
overexpressed in ST2 mouse bone marrow derived stem cells 
during osteoblast differentiation via targeting Activin receptor 
type 1 B when induced by BMP4. Despite the extensive 
research in microRNAs, their cellular functions, specifically, 
their role in the differentiation of mesynchymal stem cells is 
still in need of elucidation (18), as a result we took the initiative 
to examine the nature of the relationship between miR-210 and 
a newly emerged human mesynchymal stem cells, unrestricted 
somatic stem cells (USSCs). USSCs are recent emerged potent 
stem cells which hold great promise as cell-based therapeutics. 
Bearing these in mind, we evaluated the effect of miR-210 on 
human USSCs. The relative expression of osteoblast markers 
such as Runx2, col I and osteocalcin were assessed at molecular 
level following treatment of USSCs with miR-210. Our data 
indicated that there were an 8.6 -fold and 2.23-fold increase in 
col I and Runx2 expression respectively. Similarly, the well 
characterized marker of osteoblasts, osteocalcin, experienced a 
1.6-fold overexpression of in comparison with the untreated 
cells as control. We further confirmed the osteoblast 
differentiation by detecting calcium in USSCs treated with 
miR-210, using Alizarin red staining. Although miR-210 effect 
has been previously reported, to the best of our knowledge, no 
data has focused on the human stem cell recourse yet. Simply 
put, USSCs were selected due to their great proved potential of 
multipotency. Last of all, our data confirms that microRNA 
approach to osteoblast differentiation can have an outstanding 
merit in the cell therapy future. 
Conclusion 
On the whole, we demonstrated osteoblastic potential of miR-
210 in USSCs. In fact, here, we presented that miR-210 is capable 
of enhancing USSC differentiation into osteoblasts. This 
research may provide helpful insights into stem cell therapy for 
bone degenerative diseases not in the too distant future.  
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